AU2001273070A1 - Secretion and trafficking molecules - Google Patents
Secretion and trafficking moleculesInfo
- Publication number
- AU2001273070A1 AU2001273070A1 AU2001273070A AU7307001A AU2001273070A1 AU 2001273070 A1 AU2001273070 A1 AU 2001273070A1 AU 2001273070 A AU2001273070 A AU 2001273070A AU 7307001 A AU7307001 A AU 7307001A AU 2001273070 A1 AU2001273070 A1 AU 2001273070A1
- Authority
- AU
- Australia
- Prior art keywords
- secretion
- trafficking molecules
- trafficking
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000028327 secretion Effects 0.000 title 1
- 230000032258 transport Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21546500P | 2000-06-29 | 2000-06-29 | |
| US60/215,465 | 2000-06-29 | ||
| US23938400P | 2000-10-10 | 2000-10-10 | |
| US60/239,384 | 2000-10-10 | ||
| US25363900P | 2000-11-28 | 2000-11-28 | |
| US60/253,639 | 2000-11-28 | ||
| PCT/US2001/020704 WO2002002610A2 (en) | 2000-06-29 | 2001-06-28 | Secretion and trafficking molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001273070A1 true AU2001273070A1 (en) | 2002-01-14 |
Family
ID=27396128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001273070A Abandoned AU2001273070A1 (en) | 2000-06-29 | 2001-06-28 | Secretion and trafficking molecules |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1294884A2 (en) |
| JP (1) | JP2004528002A (en) |
| AU (1) | AU2001273070A1 (en) |
| CA (1) | CA2410679A1 (en) |
| WO (1) | WO2002002610A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| WO2002053585A2 (en) * | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Mammalian nuclear receptor cofactor cf11 and methods of use |
| WO2002053591A1 (en) * | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Mammalian nuclear receptor cofactor cf12 and methods of use |
| AU2003229752A1 (en) * | 2002-05-02 | 2003-11-17 | Bayer Healthcare Ag | Human rhomboid-related protein |
| WO2005090569A1 (en) * | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof |
| US8603992B2 (en) * | 2008-07-18 | 2013-12-10 | University Of Medicine And Dentistry Of New Jersey | Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688936A (en) * | 1992-06-11 | 1997-11-18 | The Regents Of The University Of California | Vesicle membrane transport proteins |
| EP0971950A2 (en) * | 1997-02-24 | 2000-01-19 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| AU750395B2 (en) * | 1997-09-30 | 2002-07-18 | Yale University | A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
| CA2340794A1 (en) * | 1998-08-27 | 2000-03-09 | Incyte Pharmaceuticals, Inc. | Protein transport-associated molecules |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| WO2000056767A1 (en) * | 1999-03-19 | 2000-09-28 | Human Genome Sciences, Inc. | 46 human secreted proteins |
-
2001
- 2001-06-28 WO PCT/US2001/020704 patent/WO2002002610A2/en not_active Ceased
- 2001-06-28 CA CA002410679A patent/CA2410679A1/en not_active Abandoned
- 2001-06-28 EP EP01952303A patent/EP1294884A2/en not_active Withdrawn
- 2001-06-28 AU AU2001273070A patent/AU2001273070A1/en not_active Abandoned
- 2001-06-28 JP JP2002507862A patent/JP2004528002A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1294884A2 (en) | 2003-03-26 |
| JP2004528002A (en) | 2004-09-16 |
| WO2002002610A2 (en) | 2002-01-10 |
| CA2410679A1 (en) | 2002-01-10 |
| WO2002002610A3 (en) | 2002-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001250875A1 (en) | Anti-microbial and immunostimulating composition | |
| AU2001246924A1 (en) | Decoder | |
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU2001241695A1 (en) | Dichroic polarizer and material | |
| AU2001280599A1 (en) | Compounds and methods | |
| AU2001253418A1 (en) | Compounds and methods | |
| AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
| AU2002211717A1 (en) | Stresscopins and their uses | |
| AU2002243386A1 (en) | Rf2a and rf2b transcription factors | |
| AU2001243394A1 (en) | Compounds and methods | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2001267171A1 (en) | Modified xylanases exhibiting increased thermophilicity and alkalophilicity | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2001229439A1 (en) | Bioconjugates and uses thereof | |
| AUPQ872300A0 (en) | Compounds and methods | |
| AU2001233932A1 (en) | Method and composition | |
| AU2001271400A1 (en) | Bioelastomer nanomachines and biosensors | |
| AU2001273070A1 (en) | Secretion and trafficking molecules | |
| AU2001278951A1 (en) | Compounds and methods | |
| AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
| AU2002239775A1 (en) | Chemical-library composition and method | |
| AU2002235277A1 (en) | Compounds and methods | |
| AU2002256556A1 (en) | Sea-trosy and related methods | |
| AU2001277519A1 (en) | Bio-probes and use thereof | |
| AU2002221222A1 (en) | Novel method and use |